Literature DB >> 23434585

Observation of unphosphorylated STAT3 core protein binding to target dsDNA by PEMSA and X-ray crystallography.

Edwin Nkansah1, Rahi Shah, Gavin W Collie, Gary N Parkinson, Jonathan Palmer, Khondaker M Rahman, Tam T Bui, Alex F Drake, Jarmila Husby, Stephen Neidle, Giovanna Zinzalla, David E Thurston, Andrew F Wilderspin.   

Abstract

The STAT3 transcription factor plays a central role in a wide range of cancer types where it is over-expressed. Previously, phosphorylation of this protein was thought to be a prerequisite for direct binding to DNA. However, we have now shown complete binding of a purified unphosphorylated STAT3 (uSTAT3) core directly to M67 DNA, the high affinity STAT3 target DNA sequence, by a protein electrophoretic mobility shift assay (PEMSA). Binding to M67 DNA was inhibited by addition of increasing concentrations of a phosphotyrosyl peptide. X-ray crystallography demonstrates one mode of binding that is similar to that known for the STAT3 core phosphorylated at Y705.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23434585     DOI: 10.1016/j.febslet.2013.01.065

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  26 in total

1.  Impact of the N-Terminal Domain of STAT3 in STAT3-Dependent Transcriptional Activity.

Authors:  Tiancen Hu; Jennifer E Yeh; Luca Pinello; Jaison Jacob; Srinivas Chakravarthy; Guo-Cheng Yuan; Rajiv Chopra; David A Frank
Journal:  Mol Cell Biol       Date:  2015-07-13       Impact factor: 4.272

2.  Unexpected implications of STAT3 acetylation revealed by genetic encoding of acetyl-lysine.

Authors:  Yael Belo; Zachery Mielko; Hila Nudelman; Ariel Afek; Oshrit Ben-David; Anat Shahar; Raz Zarivach; Raluca Gordan; Eyal Arbely
Journal:  Biochim Biophys Acta Gen Subj       Date:  2019-06-03       Impact factor: 3.770

3.  AD Hyper-IgE Syndrome Due to a Novel Loss-of-Function Mutation in STAT3: a Diagnostic Pursuit Won by Clinical Acuity.

Authors:  Leen Moens; Heidi Schaballie; Barbara Bosch; Arnout Voet; Xavier Bossuyt; Jean-Laurent Casanova; Stephanie Boisson-Dupuis; Stuart G Tangye; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2016-11-14       Impact factor: 8.317

4.  Prognostic and clinical significance of STAT3 and MMP9 in patients with gastric cancer: a meta-analysis of a Chinese cohort.

Authors:  Jing Chen; Xiaoxia Liu; Haiyan Jiao; Liang Peng; Zhenghao Huo; Wenjun Yang; Qin Shen; Tao Li; Qilun Liu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

5.  Signal integration and gene induction by a functionally distinct STAT3 phosphoform.

Authors:  Matthew S Waitkus; Unni M Chandrasekharan; Belinda Willard; Thomas L Tee; Jason K Hsieh; Christopher G Przybycin; Brian I Rini; Paul E Dicorleto
Journal:  Mol Cell Biol       Date:  2014-03-10       Impact factor: 4.272

6.  Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo.

Authors:  W Huang; Z Dong; Y Chen; F Wang; C J Wang; H Peng; Y He; G Hangoc; K Pollok; G Sandusky; X-Y Fu; H E Broxmeyer; Z-Y Zhang; J-Y Liu; J-T Zhang
Journal:  Oncogene       Date:  2015-06-15       Impact factor: 9.867

7.  A thiazole-derived oridonin analogue exhibits antitumor activity by directly and allosterically inhibiting STAT3.

Authors:  Xiaofei Shen; Lin Zhao; Peihao Chen; Yanqiu Gong; Dingdong Liu; Xia Zhang; Lunzhi Dai; Qingxiang Sun; Jizhong Lou; Zhong Jin; Baohua Zhang; Dawen Niu; Ceshi Chen; Xiangbing Qi; Da Jia
Journal:  J Biol Chem       Date:  2019-10-08       Impact factor: 5.157

8.  Allosteric Communication across STAT3 Domains Associated with STAT3 Function and Disease-Causing Mutation.

Authors:  Andrew T Namanja; Jianghai Wang; Ralf Buettner; Loren Colson; Yuan Chen
Journal:  J Mol Biol       Date:  2016-01-14       Impact factor: 5.469

Review 9.  STATs get their move on.

Authors:  Nancy C Reich
Journal:  JAKSTAT       Date:  2013-11-13

10.  Changes in signal transducer and activator of transcription 3 (STAT3) dynamics induced by complexation with pharmacological inhibitors of Src homology 2 (SH2) domain dimerization.

Authors:  Diana Resetca; Sina Haftchenary; Patrick T Gunning; Derek J Wilson
Journal:  J Biol Chem       Date:  2014-10-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.